Idenix Pharmaceuticals to Present at the PiperJaffray 20th Annual Health Care Conference
November 25 2008 - 9:02AM
PR Newswire (US)
CAMBRIDGE, Mass., Nov. 25 /PRNewswire-FirstCall/ -- Idenix
Pharmaceuticals, Inc. (NASDAQ:IDIX) announced today that Idenix
management will participate in the PiperJaffray Annual Health Care
Conference on Wednesday, December 3, 2008 at 4:30p.m. ET at The New
York Palace Hotel in New York, NY. The live and archived webcast of
the company presentation can be accessed under "Calendar of Events"
in the Idenix Investor Center at http://www.idenix.com/. Please log
in approximately 5-10 minutes before each event to ensure a timely
connection. The archived replays will be available on the Idenix
website for two weeks following the conference. About Idenix Idenix
Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts,
is a biopharmaceutical company engaged in the discovery and
development of drugs for the treatment of human viral and other
infectious diseases. Idenix's current focus is on the treatment of
infections caused by the hepatitis C virus and HIV. For further
information about Idenix, please refer to http://www.idenix.com/.
Idenix Pharmaceuticals Contact: Amy Sullivan 617-995-9838
(investors) Teri Dahlman 617-995-9905 (media) DATASOURCE: Idenix
Pharmaceuticals, Inc. CONTACT: Investors, Amy Sullivan, +1-
617-995-9838 or Media, Teri Dahlman, +1-617-995-9905, both of
Idenix Pharmaceuticals, Inc. Web Site: http://www.idenix.com/
Copyright
(MM) (NASDAQ:IDIX)
Historical Stock Chart
From Jun 2024 to Jul 2024
(MM) (NASDAQ:IDIX)
Historical Stock Chart
From Jul 2023 to Jul 2024